RxDoctor Payments Data
★ My doctorsLook up a doctor →

Gina Pagotto

Nurse Practitioner · Bryn Mawr, PANPI 1689991283

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.6% of the total across 474 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,807in general payments, 2019–2025

Across 474 payments — averaging $22.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • US Oncology Corporate, Inc.$903
  • AbbVie$727
  • AstraZeneca$622
  • Astellas Pharma US Inc$572
  • Pharmacyclics LLC, An Abbvie Company$426
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$10,11094%
  • Education$6976%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)42$1,201
US Oncology Corporate, Inc.7$903
AbbVie40$727
AstraZeneca(2 entities)31$622
Astellas Pharma US Inc27$572
Pharmacyclics LLC, An Abbvie Company21$426
Sanofi18$398
Seagen Inc.15$391
Novartis17$352
Amgen18$345
Bristol Myers Squibb16$343
Daiichi Sankyo Inc.16$330
Pfizer17$308
Incyte Corporation13$280
Merck12$262
E.r. Squibb & Sons, L.L.C.13$259
Pharmacosmos Therapeutics Inc.13$247
Ipsen Biopharmaceuticals, Inc10$224
Bayer10$220
Genentech USA, Inc.10$197
Eisai Inc.10$195
Takeda Pharmaceuticals U.S.A., Inc.9$190
Lilly USA, LLC6$120
Sobi, Inc5$112
AVEO Pharmaceuticals, Inc.6$111
GSK4$105
EMD Serono, Inc.5$105
Stemline Therapeutics Inc.5$102
Morphosys, US Inc.4$88
Taiho Oncology, Inc.4$72
Spectrum Pharmaceuticals Inc.3$63
Shield Therapeutics Inc1$62
Tersera Therapeutics LLC3$55
Coherus Oncology, Inc.3$51
Gilead(2 entities)3$46
Boehringer Ingelheim2$44
Mirati Therapeutics, Inc.2$42
Pharmaessentia USA Corporation2$41
Puma Biotechnology, Inc.2$40
Genmab U.S., Inc.2$40
Fresenius Kabi USA, LLC2$39
Helsinn Therapeutics (U.S.), Inc.2$33
Beone Medicines USA, Inc.1$30
Cardinal Health 108 LLC1$29
Alnylam Pharmaceuticals Inc.2$29
Amneal Pharmaceuticals LLC1$27
Karyopharm Therapeutics Inc.1$23
Caris MPI, Inc.1$22
Sun Pharmaceutical Industries Inc.1$22
Sandoz1$22
Acceleron Pharma, Inc.1$20
Recordati_rare_diseases_inc.1$20
Blueprint Medicines Corporation1$19
Beigene USA, Inc.1$19
G1 Therapeutics, Inc.1$19
Clovis Oncology, Inc.1$18
Agios Pharmaceuticals, Inc.1$18
Array Biopharma Inc1$18
Zydus Pharmaceuticals (USA) Inc.1$17
Myovant Sciences Inc.1$15

How this compares

$10,807 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania →

Other nurse practitioner in Bryn Mawr

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →